Metformin modulates autophagy in heterozygous and CRISPR-edited TSC2 primary fibroblasts
Guilherme Danielski Viola, Pedro Ozório Brum, Arthur Bandeira de Mello Garcia, Mariane da Cunha Jaeger, Nathália Freire, Eduardo Cremonese Filippi‐Chiela, Guilherme Baldo, Édina Poletto, Patrícia Ashton‐Prolla, Clévia Rosset
This study shows that metformin restores autophagy in TSC2 haploinsufficient and CRISPR-edited fibroblasts by blocking mTORC1, suggesting a potential therapeutic strategy for TSC.
bioRxiv · Aug 11, 2026 · PreprintMolecular Biology